SG10201610206VA - Hig2 and urlc10 epitope peptide and vaccines containing the same - Google Patents

Hig2 and urlc10 epitope peptide and vaccines containing the same

Info

Publication number
SG10201610206VA
SG10201610206VA SG10201610206VA SG10201610206VA SG10201610206VA SG 10201610206V A SG10201610206V A SG 10201610206VA SG 10201610206V A SG10201610206V A SG 10201610206VA SG 10201610206V A SG10201610206V A SG 10201610206VA SG 10201610206V A SG10201610206V A SG 10201610206VA
Authority
SG
Singapore
Prior art keywords
hig2
same
epitope peptide
vaccines containing
urlc10
Prior art date
Application number
SG10201610206VA
Inventor
Takuya Tsunoda
Ryuji Ohsawa
Sachiko Yoshimura
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of SG10201610206VA publication Critical patent/SG10201610206VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201610206VA 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same SG10201610206VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8997208P 2008-08-19 2008-08-19

Publications (1)

Publication Number Publication Date
SG10201610206VA true SG10201610206VA (en) 2017-01-27

Family

ID=41707003

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2013062690A SG193806A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same
SG10201610206VA SG10201610206VA (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2013062690A SG193806A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Country Status (17)

Country Link
US (1) US9119800B2 (en)
EP (1) EP2328600B9 (en)
JP (1) JP5633025B2 (en)
KR (1) KR101713581B1 (en)
CN (2) CN102186491B (en)
AU (1) AU2009283763B2 (en)
BR (1) BRPI0917391A2 (en)
CA (1) CA2734467C (en)
DK (1) DK2328600T3 (en)
ES (1) ES2566011T3 (en)
HK (1) HK1157204A1 (en)
IL (1) IL211117A (en)
MX (2) MX337756B (en)
RU (1) RU2529373C2 (en)
SG (2) SG193806A1 (en)
TW (2) TWI580431B (en)
WO (1) WO2010021112A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI438207B (en) * 2007-02-21 2014-05-21 Oncotherapy Science Inc Peptide vaccines for cancers expressing tumor-associated antigens
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
PT2640842T (en) * 2010-11-17 2018-10-12 Providence Health & Services Oregon D/B/A Providence Portland Medical Center Methods and compositions for inducing an immune response to egfrviii
JP6255594B2 (en) 2012-07-10 2018-01-10 オンコセラピー・サイエンス株式会社 LY6K epitope peptide of Th1 cell and vaccine containing the same
MX2017001651A (en) * 2014-08-04 2017-04-27 Oncotherapy Science Inc Urlc10-derived peptide and vaccine containing same.
CN107847573B (en) 2015-08-10 2021-12-31 东丽株式会社 Immune inducer
MX2018001673A (en) 2015-08-12 2018-05-07 Oncotherapy Science Inc Depdc1-derived peptide and vaccine containing same.
KR20200014294A (en) 2017-04-26 2020-02-10 유레카 쎄라퓨틱스, 인코포레이티드 Chimeric Antibody / T-Cell Receptor Constructs and Uses thereof
CN114058590A (en) 2017-06-20 2022-02-18 居里研究所 SUV39H1 deficient immune cells
CN115300609A (en) * 2021-05-08 2022-11-08 西湖大学 Use of hypoxia-inducible lipid droplet-associated protein (HIPDA) for preventing or treating hyperlipidemia-associated diseases

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
ATE464383T1 (en) * 1999-08-05 2010-04-15 Greenpeptide Co Ltd TUMOR ANTIGEN
WO2001023426A2 (en) 1999-09-30 2001-04-05 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
WO2002030268A2 (en) 2000-10-13 2002-04-18 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
US20030232350A1 (en) 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7727714B2 (en) 2003-08-20 2010-06-01 Oncotherapy Science, Inc. Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma
WO2005123122A1 (en) * 2004-06-21 2005-12-29 Green Peptide Co., Ltd. Peptide vaccine for cancer therapy
EP2311983A1 (en) 2005-02-10 2011-04-20 Oncotherapy Science, Inc. Method of treating bladder cancer using siRNA
JP4461179B2 (en) 2005-02-25 2010-05-12 オンコセラピー・サイエンス株式会社 Peptide vaccine against lung cancer expressing TTK, URLC10, or KOC1 polypeptide
WO2006093337A1 (en) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
EP1907580A2 (en) 2005-07-28 2008-04-09 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
WO2007029778A1 (en) * 2005-09-07 2007-03-15 Nec Corporation Hla-binding peptide, dna fragment encoding the peptide, and recombinant vector
JP4840858B2 (en) 2006-03-16 2011-12-21 学校法人慶應義塾 Cancer vaccine
MX2008015939A (en) 2006-06-16 2009-02-11 Univ Kumamoto Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same.
TWI438207B (en) * 2007-02-21 2014-05-21 Oncotherapy Science Inc Peptide vaccines for cancers expressing tumor-associated antigens
EP2185732A1 (en) 2007-07-30 2010-05-19 Oncotherapy Science, Inc. Cancer associated gene ly6k
TW201000115A (en) 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
MX355054B (en) 2018-04-03
EP2328600B9 (en) 2016-07-13
JP2012500184A (en) 2012-01-05
TW201019952A (en) 2010-06-01
AU2009283763A2 (en) 2011-07-07
CN104958753A (en) 2015-10-07
CN102186491A (en) 2011-09-14
TWI580431B (en) 2017-05-01
DK2328600T3 (en) 2016-03-29
HK1157204A1 (en) 2012-06-29
US20110243973A1 (en) 2011-10-06
EP2328600B1 (en) 2016-01-27
TW201500055A (en) 2015-01-01
IL211117A0 (en) 2011-04-28
CN104958753B (en) 2018-09-25
TWI543767B (en) 2016-08-01
EP2328600A4 (en) 2013-03-06
BRPI0917391A2 (en) 2015-12-01
RU2529373C2 (en) 2014-09-27
IL211117A (en) 2017-03-30
CN102186491B (en) 2015-06-10
KR20110045052A (en) 2011-05-03
EP2328600A1 (en) 2011-06-08
MX2011001883A (en) 2011-03-29
CA2734467A1 (en) 2010-02-25
KR101713581B1 (en) 2017-03-08
CA2734467C (en) 2017-10-03
AU2009283763B2 (en) 2014-06-19
JP5633025B2 (en) 2014-12-03
SG193806A1 (en) 2013-10-30
MX337756B (en) 2016-03-17
WO2010021112A1 (en) 2010-02-25
AU2009283763A1 (en) 2010-02-25
US9119800B2 (en) 2015-09-01
RU2011110376A (en) 2012-09-27
ES2566011T3 (en) 2016-04-08

Similar Documents

Publication Publication Date Title
EP2326718A4 (en) Inhbb epitope peptides and vaccines containing the same
HK1157204A1 (en) Hig2 and urlc10 epitope peptide and vaccines containing the same hig2 urlc10
IL209967A0 (en) Cdca1 epitope peptides and vaccines containing the same
IL209869A0 (en) Iqgap3 epitope peptides and vaccines containing the same
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
IL214435A0 (en) Foxm1 peptides and vaccines containing the same
IL229926A (en) Neil3 peptides and vaccines including the same
IL232461A0 (en) Melk epitope peptides and vaccines containing the same
HK1157397A1 (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same rab6kifl/kif20a
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
EP2614146A4 (en) Ttll4 peptides and vaccines containing the same
ZA201104890B (en) Wdrpuh epitope peptides and vaccines containing the same
IL219927A0 (en) Mybl2 peptides and vaccines containing the same